The Era of Geographic Atrophy Treatment Begins

New Retina Radio by Eyetube
23/02/2023 11 min
The Era of Geographic Atrophy Treatment Begins

Listen "The Era of Geographic Atrophy Treatment Begins"

Descargar episodio

Episode Synopsis

The FDA approval of pegcetacoplan (Syfovre, Apellis Pharmaceuticals) is a historic moment for the field of retina, finally providing a treatment option for patients with geographic atrophy. Allen C. Ho, MD, and Robert L. Avery, MD, share their initial reactions to the approval and discuss the potential effect on patient care and clinical practice. 

More episodes of the podcast New Retina Radio by Eyetube

Late-Breaking Talks at AAO '25: Gene Therapy for RP and NPDR 23/10/2025
New Retina Radio Journal Club w/ VBS: Time-Driven Cost Analysis of PRP: Dollars, Minutes, and Patient Care 10/10/2025
The Nuts and Bolts of GA Therapy: The Opening Sessions 09/10/2025
Keeping Patients at the Center of GA Therapy: Preserving Vision vs Restoring Vision 02/10/2025
Keeping Patients at the Center of GA Therapy: Dosing Schedules, AREDS Vitamins, and Photobiomodulation 02/10/2025
Keeping Patients at the Center of GA Therapy: Patient Education and Setting Expectations 02/10/2025
Keeping Patients at the Center of GA Therapy: Social Impact and Early Intervention 02/10/2025
New Retina Radio Journal Club w/ VBS: Aflibercept 8 mg in nAMD: Outcomes After Switching From Faricimab 26/09/2025
ASRS '25: ReCLAIM-2 and Continuous Glucose Monitoring in NPDR 04/09/2025
ASRS '25: PORTAL 5-year Data in Wet AMD, and Home OCT vs Human Graders 21/08/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA